脑出血患者血清沉默信息调节因子1表达水平与疾病严重程度及预后的相关性OA
Correlations of serum Sirt1 expression level with disease severity and prognosis in patients with intracerebral hemorrhage
目的 分析血清沉默信息调节因子1(Sirt1)表达水平与脑出血(ICH)患者疾病严重程度及预后的相关性,并评估其在ICH患者预后预测中的价值.方法 纳入60例ICH患者作为ICH组,以及同期69例健康体检者作为对照组.收集所有受试者的基线资料,并于入院24 h内采集血清样本.采用酶联免疫吸附分析(ELISA)测定血清Sirt1表达水平.根据美国国立卫生研究院卒中量表(NIHSS)评分评估ICH患者神经功能缺损程度,并将患者分为轻度组(0~4分,n=8)、中度组(5~15分,n=37)和重度组(≥16分,n=15);根据出血部位分为幕上组(n=48)和幕下组(n=12);根据发病后90 d改良Rankin量表(mRS)评分分为预后良好组(0~2分,n=16)和预后不良组(3~6分,n=44).通过Spearman相关分析明确血清Sirt1表达水平与ICH患者脑出血量、格拉斯哥昏迷量表(GCS)评分、NIHSS评分及90 d mRS评分的相关性.运用Logistic回归模型筛选ICH发生的独立影响因素.采用受试者工作特征(ROC)曲线评估血清Sirt1表达水平对ICH的诊断效能及预后预测价值.结果 ICH组血清Sirt1表达水平低于对照组,差异有统计学意义(P<0.05).轻度组、中度组和重度组患者血清Sirt1表达水平呈依次显著下降趋势(P<0.05).预后不良组血清Sirt1表达水平低于预后良好组,差异有统计学意义(P<0.05).幕上组中,血清Sirt1表达水平与出血量呈负相关(rs=-0.527 8,P<0.05),与GCS评分呈正相关(rs=0.558 8,P<0.05).幕下组血清Sirt1水平与GCS评分呈正相关(rs=0.897 5,P<0.05).血清Sirt1表达水平与NIHSS评分、90 d mRS评分呈负相关(rs=-0.804 2、-0.859 0,P<0.05).Logistic回归分析显示,高血压病史、吸烟史是ICH的独立危险因素,血清Sirt1是其独立保护因素(P<0.05).联合高血压病史、吸烟史、饮酒史及血清Sirt1水平构建模型,其诊断ICH的曲线下面积(AUC)为0.930.血清Sirt1水平对ICH预后的预测效能(AUC=0.963)优良.结论 ICH患者血清Sirt1表达水平显著降低,且与疾病严重程度及预后密切相关,提示Sirt1可作为预测ICH发生与预后的潜在生物标志物,并为神经保护研究提供新靶点.
Objective To analyze the correlation between the expression level of serum silent in-formation regulator 1(Sirt1)and disease severity,prognosis in patients with intracerebral hemorrhage(ICH),and to evaluate its value in predicting the prognosis of ICH patients.Methods A total of 60 ICH patients were enrolled as ICH group,and 69 healthy individuals undergoing physical examination during the same period were selected as control group.Baseline data of all subjects were collected,and serum samples were obtained within 24 hours of admission.Serum Sirt1 expression levels were measured using enzyme-linked immunosorbent assay(ELISA).The degree of neurological deficit inICH pa-tients was assessed using the National Institutes of Health Stroke Scale(NIHSS)score,and patients were divided into mild(0 to 4 points,n=8),moderate(5 to 15 points,n=37),and severe(≥16 points,n=15)groups.According to the bleeding site,patients were classified into supratentori-al group(n=48)and infratentorial group(n=12).Based on the 90-day modified Rankin Scale(mRS)score,patients were categorized into favorable prognosis group(0 to 2 points,n=16)and poor prognosis group(3 to 6 points,n=44).Spearman correlation analysis was used to determine the correlations between serum Sirt1 expression level and ICH volume,Glasgow Coma Scale(GCS)score,NIHSS score,90-day mRS score in ICH patients.Logistic regression models were employed to identify independent influencing factors for the occurrence of ICH.Receiver operating characteris-tic(ROC)curves were used to evaluate the diagnostic efficacy and prognostic predictive value of se-rum Sirt1 expression level for ICH.Results The serum Sirt1 expression level in the ICH group was significantly lower than that in the control group(P<0.05).The serum Sirt1 expression levels in the mild,moderate and severe groups showed a decreasing trend(P<0.05).The serum Sirt1 ex-pression level in the poor prognosis group was significantly lower than that in the favorable prognosis group(P<0.05).In the supratentorial group,serum Sirt1 expression level was negatively correla-ted with ICH volume(rs=-0.527 8,P<0.05)and positively correlated with GCS score(rs=0.558 8,P<0.05).In the infratentorial group,serum Sirt1 level was positively correlated with GCS score(rs=0.897 5,P<0.05).Serum Sirt1 expression level was negatively correlated with NIHSS score and 90-day mRS score(rs=-0.804 2,-0.859 0,P<0.05).Logistic regression analysis showed that history of hypertension and smoking were independent risk factors for ICH,while serum Sirt1 was independent protective factor(P<0.05).The model constructed by combi-ning history of hypertension,smoking,alcohol consumption and serum Sirt1 level yielded an area under the curve(AUC)of 0.930 for diagnosing ICH.The predictive efficacy of serum Sirt1 level for ICH prognosis was excellent(AUC=0.963).Conclusion Serum Sirt1 expression level is signifi-cantly decreased in ICH patients and is closely correlated with disease severity and prognosis,sug-gesting that Sirt1 may serve as a potential biomarker for predicting the occurrence and prognosis of ICH and provide a new target for neuroprotective research.
朱琳;蒋婧;王嘉浩;季林玲;祝依然;梁景岩;王英歌
扬州大学,江苏扬州,225000||扬州大学附属医院神经内科,江苏扬州,225000扬州大学,江苏扬州,225000||扬州大学附属医院神经内科,江苏扬州,225000扬州大学附属泰州第二人民医院神经内科,江苏泰州,225300扬州大学,江苏扬州,225000||扬州大学附属医院神经内科,江苏扬州,225000扬州大学,江苏扬州,225000||扬州大学附属医院神经内科,江苏扬州,225000扬州大学,江苏扬州,225000扬州大学,江苏扬州,225000||扬州大学附属医院神经内科,江苏扬州,225000
医药卫生
脑出血沉默信息调节因子1神经功能缺损美国国立卫生研究院卒中量表改良Rankin量表疾病严重程度生物标志物受试者工作特征曲线
intracerebral hemorrhagesilent information regulator 1neurological deficitNa-tional Institutes of Health Stroke Scalemodified Rankin Scaledisease severitybiomarkerreceiv-er operating characteristic curve
《实用临床医药杂志》 2026 (15)
34-41,8
国家自然科学基金项目(82370517)扬州市社会发展项目(YZ2023067)
评论